Literature DB >> 23482625

Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing.

Esther M Opmeer1, Rudie Kortekaas, Marie-José van Tol, Nic J A van der Wee, Saskia Woudstra, Mark A van Buchem, Brenda W J H Penninx, Dick J Veltman, André Aleman.   

Abstract

Neuropeptide Y (NPY) has been associated with stress reactivity in affective disorders and is most densely expressed in the amygdala. An important stressor associated with affective disorders is the experience of childhood emotional maltreatment (CEM). We investigated whether the interaction of NPY risk genotype and CEM would affect brain activation. From The Netherlands Study of Depression and Anxiety, 33 healthy controls and 85 patients with affective disorders were scanned with functional magnetic resonance imaging while making gender decisions of emotional facial expressions. Results showed interactions between genotype and CEM, within carriers of the risk genotype, CEM was associated with higher amygdala activation, whereas CEM did not influence activation in non-risk carriers. In the posterior cingulate cortex (PCC), less activation was seen in those with CEM and the risk genotype, whereas genotype did not influence PCC activation in those without CEM. In addition, those carrying the risk genotype and with experience of CEM made a faster gender decision than those without CEM. Thus, the combined effect of carrying NPY risk genotype and a history of CEM affected amygdala and PCC reactivity, areas related to emotion, self-relevance processing and autobiographical memory. These results are consistent with the notion that the combination of risk genotype and CEM may cause hypervigilance.

Entities:  

Keywords:  NPY; amygdala; childhood abuse; depression; fMRI

Mesh:

Substances:

Year:  2013        PMID: 23482625      PMCID: PMC4014098          DOI: 10.1093/scan/nst025

Source DB:  PubMed          Journal:  Soc Cogn Affect Neurosci        ISSN: 1749-5016            Impact factor:   3.436


  72 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

2.  Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study.

Authors:  Amit Anand; Yu Li; Yang Wang; Kathryn Gardner; Mark J Lowe
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

Review 3.  Neurobiology of emotion perception I: The neural basis of normal emotion perception.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

Review 4.  The psychometric properties of the Composite International Diagnostic Interview.

Authors:  G Andrews; L Peters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-02       Impact factor: 4.328

Review 5.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

6.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

7.  Rapid onset of comorbidity of common mental disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  R de Graaf; R V Bijl; M ten Have; A T F Beekman; W A M Vollebergh
Journal:  Acta Psychiatr Scand       Date:  2004-01       Impact factor: 6.392

8.  Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.

Authors:  Katharina Domschke; Udo Dannlowski; Christa Hohoff; Patricia Ohrmann; Jochen Bauer; Harald Kugel; Peter Zwanzger; Walter Heindel; Jürgen Deckert; Volker Arolt; Thomas Suslow; Bernhard T Baune
Journal:  Eur Neuropsychopharmacol       Date:  2009-10-24       Impact factor: 4.600

9.  Amygdala hyperactivation in untreated depressed individuals.

Authors:  Marco A M Peluso; David C Glahn; Koji Matsuo; E Serap Monkul; Pablo Najt; Frank Zamarripa; Jinqi Li; Jack L Lancaster; Peter T Fox; Jia-Hong Gao; Jair C Soares
Journal:  Psychiatry Res       Date:  2009-06-28       Impact factor: 3.222

10.  5-HTTLPR-environment interplay and its effects on neural reactivity in adolescents.

Authors:  Nicholas D Walsh; Tim Dalgleish; Valerie J Dunn; Rosemary Abbott; Michelle C St Clair; Matthew Owens; Graeme Fairchild; William S Kerslake; Lucy V Hiscox; Luca Passamonti; Michael Ewbank; Maria Ban; Andrew J Calder; Ian M Goodyer
Journal:  Neuroimage       Date:  2012-08-21       Impact factor: 6.556

View more
  2 in total

1.  The role of neuropeptide-Y in nandrolone decanoate-induced attenuation of antidepressant effect of exercise.

Authors:  Jovana Joksimovic; Dragica Selakovic; Milovan Matovic; Ivan Zaletel; Nela Puskas; Gvozden Rosic
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

2.  The complex neurobiology of resilient functioning after childhood maltreatment.

Authors:  Konstantinos Ioannidis; Adrian Dahl Askelund; Rogier A Kievit; Anne-Laura van Harmelen
Journal:  BMC Med       Date:  2020-02-13       Impact factor: 11.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.